Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides

As the limitations of antiretroviral drug therapy, such as toxicity and resistance, become evident, interest in alternative therapeutic approaches for human immunodeficiency virus (HIV) infection is growing. We developed the first gene therapeutic strategy targeting entry of a broad range of HIV typ...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Egelhofer, Marc, Brandenburg, Gunda, Martinius, Holger, Schult-Dietrich, Patricia, Melikyan, Gregory, Kunert, Renate, Baum, Christopher, Choi, Ingrid, Alexandrov, Alexander, von Laer, Dorothee
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2004
Soggetti:	Vaccines and Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368739/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14694088/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.2.568-575.2004
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!